Discover how AI chatbots are reshaping weight-loss planning with precision and variety, yet face challenges in balancing macronutrients for optimal health.
Why could we see more deal-making at this year’s J. P. Morgan Healthcare conference? Why are investors concerned about a slowdown in U.S. biotech innovation?
Opioid misuse and specifically opioid use disorder (OUD), continues to represent a significant U.S. public health threat, with more than 6 million Americans aged 12
This column is from Trendlines, The Boston Globe’s business newsletter that covers the forces shaping the economy in Boston and beyond. If you’d like to
A groundbreaking UK study led by the University of Liverpool has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time
Asthma, atopic dermatitis or Hashimoto’s thyroiditis as concomitant diseases are risk factors for clinical features associated with a poor prognosis in circular hair loss, also
A consortium including scientists from the Tropical Institute at LMU University Hospital has demonstrated the effectiveness of a new antibiotic.
A Mount Sinai-led team of researchers has enhanced an artificial intelligence (AI)-powered algorithm to analyze video recordings of clinical sleep tests, ultimately improving accurate diagnosis
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new
For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.